Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-

Go back to Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-
(NASDAQ: LQDA) Delayed: 38.86 --0 (-0%)
Previous Close $38.86    52 Week High $ 
Open $38.86    52 Week Low $ 
Day High $38.86    P/E N/A 
Day Low $38.86    EPS $ 
Volume 2,101